Recent advances in ocular drug delivery

被引:240
作者
Achouri, Djamila [1 ,2 ,4 ]
Alhanout, Kamel [3 ,4 ,5 ]
Piccerelle, Philippe [1 ,4 ]
Andrieu, Veronique [3 ,4 ]
机构
[1] Aix Marseille Univ, UMR CNRS IRD 7263 237, IMBE, Marseille, France
[2] These CIFRE Horus Pharma, St Laurent Du Var, France
[3] Aix Marseille Univ, Fac Med & Pharm, UMR CNRS 6236, Unite Rech Malad Infect & Trop Emergentes URMITE, Marseille, France
[4] Fac Pharm Marseille, Lab Pharm Galen Ind & Cosmetol, Marseille, France
[5] Alandalus Univ, Fac Pharm, Dept Pharmaceut Sci, Alkadmus, Syria
关键词
Bioavailability; drug delivery systems; in-situ gelling system; particulate systems; SUSTAINED OPHTHALMIC DELIVERY; SODIUM HYALURONATE EYEDROPS; LIPID NANOPARTICLES SLN; IN-VITRO; CHITOSAN NANOPARTICLES; CYCLOSPORINE-A; TIMOLOL MALEATE; SYSTEM; LIPOSOMES; FORMULATION;
D O I
10.3109/03639045.2012.736515
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Amongst the various routes of drug delivery, the field of ocular drug delivery is one of the most interesting and challenging endeavors facing the pharmaceutical scientist. Recent research has focused on the characteristic advantages and limitations of the various drug delivery systems, and further research will be required before the ideal system can be developed. Administration of drugs to the ocular region with conventional delivery systems leads to short contact time of the formulations on the epithelium and fast elimination of drugs. This transient residence time involves poor bioavailability of drugs which can be explained by the tear production, non-productive absorption and impermeability of corneal epithelium. Anatomy of the eye is shortly presented and is connected with ophthalmic delivery and bioavailability of drugs. In the present update on ocular dosage forms, chemical delivery systems such as prodrugs, the use of cyclodextrins to increase solubility of various drugs, the concept of penetration enhancers and other ocular drug delivery systems such as polymeric gels, bioadhesive hydrogels, in-situ forming gels with temperature-, pH-, or osmotically induced gelation, combination of polymers and colloidal systems such as liposomes, niosomes, cubosomes, microemulsions, nanoemulsions and nanoparticles are discussed. Novel ophthalmic delivery systems propose the use of many excipients to increase the viscosity or the bioadhesion of the product. New formulations like gels or colloidal systems have been tested with numerous active substances by in vitro and in vivo studies. Sustained drug release and increase in drug bioavailability have been obtained, offering the promise of innovation in drug delivery systems for ocular administration. Combining different properties of pharmaceutical formulations appears to offer a genuine synergy in bioavailability and sustained release. Promising results are obtained with colloidal systems which present very comfortable conditions of use and prolonged action.
引用
收藏
页码:1599 / 1617
页数:19
相关论文
共 93 条
[1]   Niosome-Encapsulated Gentamicin for Ophthalmic Controlled Delivery [J].
Abdelbary, Ghada ;
El-gendy, Nashwa .
AAPS PHARMSCITECH, 2008, 9 (03) :740-747
[2]  
Abdulrazik M, 2001, OCULAR DELIVERY CYCL
[3]   Improved pharmacodynamics of timolol maleate from a mucoadhesive niosomal ophthalmic drug delivery system [J].
Aggarwal, D ;
Kaur, IP .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2005, 290 (1-2) :155-159
[4]   Study of the extent of ocular absorption of acetazolamide from a developed niosomal formulation, by microdialysis sampling of aqueous humor [J].
Aggarwal, Deepika ;
Pal, Dhananjay ;
Mitra, Ashim K. ;
Kaur, Indu P. .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2007, 338 (1-2) :21-26
[5]   Nanoemulsion as a Potential Ophthalmic Delivery System for Dorzolamide Hydrochloride [J].
Ammar, Hussein O. ;
Salama, H. A. ;
Ghorab, M. ;
Mahmoud, A. A. .
AAPS PHARMSCITECH, 2009, 10 (03) :808-819
[6]  
Bague S, 2006, US patent, Patent No. 0100288
[7]   Ion-activated in situ gelling systems for sustained ophthalmic delivery of ciprofloxacin hydrochloride [J].
Balasubramaniam, J ;
Pandit, JK .
DRUG DELIVERY, 2003, 10 (03) :185-191
[8]  
Benita S., 2003, Method and composition for dry eye treatment, Patent No. [US0108626, 0108626]
[9]   Gels and liposomes in optimized ocular drug delivery:: Studies on ciprofloxacin formulations [J].
Budai, Livia ;
Hajdu, Maria ;
Budai, Marianna ;
Grof, Pal ;
Beni, Szabolcs ;
Noszal, Bela ;
Klebovich, Imre ;
Antal, Istvan .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2007, 343 (1-2) :34-40
[10]   Rheological evaluation of Gelrite® in situ gels for ophthalmic use [J].
Carlfors, J ;
Edsman, K ;
Petersson, R ;
Jornving, K .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 1998, 6 (02) :113-119